Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire
Restricted accessResearch articleFirst published online August, 2008
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire
Brief cognitive performance tests and self-report measures of neuropsychological symptoms have been proposed for screening purposes in multiple sclerosis (MS) clinics. To better understand the reliability of screening methods, two tests, the Symbol Digit Modalities Test (SDMT) and the MS Neuropsychological Screening Questionnaire (MSNQ), were administered to 76 patients with MS and 25 healthy controls, matched on demographic characteristics.
Methods
Tests were administered at monthly intervals, over 6 months. In addition, the Beck Depression Inventory Fast Screen for medical patients (BDIFS) was administered to monitor for changes in depression. Our objectives were to determine the reliability of these measures and the relative contribution of cognitive impairment and depression in predicting self-report MSNQ scores.
Results
Results showed that both the SDMT and MSNQ have good to excellent reproducibility over repeated testing. In MS, there are minimal practice effects over successive tests, in the order of 0.2 SD for SDMT and minimal change in the MSNQ. Regression analyses modeled to predict MSNQ based on SDMT and BDIFS showed significant contribution for both, but with the majority of variance being accounted for depression.
Conclusions
We conclude that these brief screening tests provide some independent information about the mental status of patients with MS and are reliable, even when used in monthly, successive examinations.
1 Rao SM Leo GJ Bernardin L Unverzagt F . Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology1991; 41: 685–691.
2.
2 Benedict RHB Cookfair D Gavett R . Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc2006; 12: 549–558.
3.
3 Rao SM Leo GJ Ellington L . Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology1991; 41: 692–696.
4.
4 Beatty WW Blanco CR Wilbanks SL Paul RH . Demographic, clinical, and cognitive characteristics of multiple sclerosis patients who continue to work. J Neurol Rehabil1995; 9: 167–173.
5.
5 Benedict RHB Wahlig E Bakshi R . Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci2005; 231: 29–34.
6.
6 Langdon DW Thompson AJ . Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler1999; 5: 94–100.
7.
7 Benedict RHB Shapiro A Priore RL . Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Mult Scler2001; 6: 391–396.
8.
8 Benedict RHB Priore RL Miller C . Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci2001; 13: 70–76.
9.
9 Benedict RHB Munschauer F Zarevics P . Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients. J Neurol (in press).
10.
10 Krupp LB Christodoulou C Melville P . Donepezil improves memory in multiple sclerosis in a randomized clinical trial. Neurology2004; 63: 1579–1585.
11.
11 Smith A . Symbol Digit Modalities Test: manual.Los Angeles: Western Psychological Services; 1982.
12.
12 Benedict RHB Cox D Thompson LL . Reliable screening for neuropsychological impairment in MS. Mult Scler2004; 10: 675–678.
13.
13 Benedict RHB . Effects of using same vs. alternate form memory tests in short-interval, repeated assessment in multiple sclerosis. J Int Neuropsychol Soc2005; 11: 727–736.
14.
14 Houtchens MK Benedict RHB Killiany R . Thalamic atrophy and cognition in multiple sclerosis. Neurology.2007; 69: 113–123.
15.
15 Christodoulou C Krupp LB Liang Z . Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology2003; 60: 1793–1798.
16.
16 Bermel RA Bakshi R Tjoa C . Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol2002; 59: 275–280.
17.
17 Benedict RHB Weinstock-Guttman B Fishman I . Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol2004; 61: 226–230.
18.
18 Benedict RHB Bruce JM Dwyer MG . Neocortical atrophy, third ventricular width, and cognitive dysfunciton in multiple sclerosis. Arch Neurol2006; 63: 1301–1306.
19.
19 Benedict RHB Zivadinov R . Predicting neuropsychological abnormalities in multiple sclerosis. J Neurol Sci2006; 245: 67–72.
20.
20 Parmenter BA Weinstock-Guttman B Garg N . Screening for cognitive impairment in MS using the Symbol Digit Modalities Test. Mult Scler2006; 13: 52–57.
21.
21 Carone D Benedict RHB Munschauer FE . Interpreting patient/informant discrepancies of reported cognitive symptoms in MS. J Int Neuropsychol Soc2005; 11: 574–583.
22.
22 Benedict RHB . Integrating cognitive function screening and assessment into the routine care of multiple sclerosis patients. CNS Spectr2005; 10: 384–391.
23.
23 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Ann Neurol1983; 13: 227–231.
24.
24 McDonald WI Compston A Edan G . Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121–127.
25.
25 Lublin FD Reingold SC Lublin FD Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996; 46: 907–911 [see comment].
26.
26 Benedict RHB Fischer JS Archibald CJ . Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol2002; 16: 381–397.
27.
27 Benton AL Sivan AB Hamsher K . Contributions to neuropsychological assessment.2nd ed.New York: Oxford University Press; 1994.
28.
28 Delis DC Kramer JH Kaplan E Ober BA . California verbal learning test manual. 2nd ed, Adult Version. San Antonio, Texas: Psychological Corporation; 2000.
29.
29 Benedict RHB . Brief visuospatial memory test – revised: professional manual.Odessa, Florida: Psychological Assessment Resources, Inc; 1997.
30.
30 Gronwall DMA . Paced auditory serial addition task: a measure of recovery from concussion. Percept Mot Skills1977; 44: 367–373.
31.
31 Rao SM; . A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis. 1991.
32.
32 Delis DC Kaplan E Kramer JH . Delis–Kaplan executive function system.San Antonio, Texas: Psychological Corporation; 2001.
33.
33 Benedict RHB Fishman I McClellan MM . Validity of the Beck Depression Inventory – Fast Screen in multiple sclerosis. Mult Scler2003; 9: 393–396.
34.
34 Benedict RHB Munschauer FE Linn R . Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler2003; 9: 95–101.
35.
35 Anastasi A . Psychological testing.6th ed.Macmillan Publishing Company; 1988.
36.
36 Iverson GL Lovell MR Collins MW . Interpreting change on ImPACT following sport concussion. Clin Neuropsychol2003; 17: 460–467.
37.
37 Amato MP Bartolozzi ML Zipoli V . Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology2004; 63: 89–93.
38.
38 Kahn RL . Memory complaint and impairment in the aged: the effect of depression and altered brain function. Arch Gen Psychiatry1975; 32: 1569–1573.
39.
39 Riege WH . Self-report and tests of memory aging. Clin Gerontol1982; 1: 23–36.
40.
40 Bruce JM Arnett PA . Self-reported everyday memory and depression in patients with multiple sclerosis. J Clin Exp Neuropsychol2004; 26: 200–214.
41.
41 O'Brien A Gaudino-Goering E Shawaryn M . Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes. Arch Clin Neuropsychol2007; 22: 933–948.
42.
42 Rourke SB Halman MH Bassel C . Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. J Clin Exp Neuropsychol1999; 21: 737–756.
43.
43 Elixhauser A Leidy NK Meador K . The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy. Epilepsy Res1999; 37: 13–24.
